China E-prescribing Market Size & Outlook, 2023-2030

The e-prescribing market in China is expected to reach a projected revenue of US$ 621.8 million by 2030. A compound annual growth rate of 30.6% is expected of China e-prescribing market from 2024 to 2030.
Revenue, 2023 (US$M)
$95.7
Forecast, 2030 (US$M)
$621.8
CAGR, 2024 - 2030
30.6%
Report Coverage
China

China e-prescribing market highlights

  • The China e-prescribing market generated a revenue of USD 95.7 million in 2023 and is expected to reach USD 621.8 million by 2030.
  • The China market is expected to grow at a CAGR of 30.6% from 2024 to 2030.
  • In terms of segment, solution was the largest revenue generating product in 2023.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


E-prescribing market data book summary

Market revenue in 2023USD 95.7 million
Market revenue in 2030USD 621.8 million
Growth rate30.6% (CAGR from 2023 to 2030)
Largest segmentSolution
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSolution, Services
Key market players worldwideOracle Corp, Allscripts Healthcare, Epic Systems Corporation, Athenahealth, NXGN, McKesson Corp, UnitedHealth Group Inc, DrFirst, Surescripts, Veradigm Inc


Other key industry trends

  • In terms of revenue, China accounted for 2.6% of the global e-prescribing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Australia e-prescribing market is projected to lead the regional market in terms of revenue in 2030.
  • Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 811.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

E-Prescribing Market Companies

Name Profile # Employees HQ Website

China e-prescribing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to e-prescribing market will help companies and investors design strategic landscapes.


Solution was the largest segment with a revenue share of 58.73% in 2023. Horizon Databook has segmented the China e-prescribing market based on solution, services covering the revenue growth of each sub-segment from 2018 to 2030.


China is considered as one of the high healthcare spending countries, which will expand investment opportunities pertaining to clinical research. Major companies are focusing on prescription systems, creating more avenues for e-prescription software.

In 2018, China introduced an Inpatient Medication Order Entry System which allowed doctors to recommend medication using a handheld device or computer, with their login details. Pharmacists could access the records to verify the prescription and affix a QR code to the prescription.

Chinese e-prescription market has exhibited significant growth, which can have a positive impact on the Chinese market. China exhibits high growth opportunities, owing to high population and improving healthcare facilities for untargeted medical needs.

Reasons to subscribe to China e-prescribing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China e-prescribing market databook

  • Our clientele includes a mix of e-prescribing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China e-prescribing market , including forecasts for subscribers. This country databook contains high-level insights into China e-prescribing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China e-prescribing market size, by product, 2018-2030 (US$M)

China E-Prescribing Market Outlook Share, 2023 & 2030 (US$M)

China e-prescribing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more